| Ginger S Stickney, PHD, CCC-A | |
|
101 The City Dr S, Orange, CA 92868-3201 | |
| (714) 456-8068 | |
| (714) 456-2979 |
| Full Name | Ginger S Stickney |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 23 Years |
| Location | 101 The City Dr S, Orange, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457524878 | NPI | - | NPPES |
| 3874 | Other | CA | HEARING AID DISPENSER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 3874 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Head And Neck Surgeons | 9032191788 | 18 |
News Archive
QLT Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for QLT091001, its oral synthetic retinoid, for the treatment of Leber Congenital Amaurosis (LCA). LCA is an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
With the rapid and continuous advances in biotechnology, scientists are better able to see inside the nucleus of a cell to unlock the secrets of its genetic material. However, what happens outside of the nucleus has, in many ways, remained a mystery. Now, researchers with the National Institutes of Health are closer to understanding how activity outside of the nucleus determines a cell's behavior.
Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.
In this week's issue of Science, researchers from the National Institute of Environmental Health Sciences (NIEHS) and Umea University in Sweden report an important discovery about a critical new role that an enzyme called DNA polymerase epsilon plays in replicating DNA in higher organisms such as yeast and perhaps even humans.
› Verified 5 days ago
| Provider Name | University Head & Neck Surgeons |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669437075 PECOS PAC ID: 9032191788 Enrollment ID: O20040604000997 |
News Archive
QLT Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for QLT091001, its oral synthetic retinoid, for the treatment of Leber Congenital Amaurosis (LCA). LCA is an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
With the rapid and continuous advances in biotechnology, scientists are better able to see inside the nucleus of a cell to unlock the secrets of its genetic material. However, what happens outside of the nucleus has, in many ways, remained a mystery. Now, researchers with the National Institutes of Health are closer to understanding how activity outside of the nucleus determines a cell's behavior.
Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.
In this week's issue of Science, researchers from the National Institute of Environmental Health Sciences (NIEHS) and Umea University in Sweden report an important discovery about a critical new role that an enzyme called DNA polymerase epsilon plays in replicating DNA in higher organisms such as yeast and perhaps even humans.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ginger S Stickney, PHD, CCC-A Po Box 513700, Los Angeles, CA 90051-3700 Ph: (714) 456-8068 | Ginger S Stickney, PHD, CCC-A 101 The City Dr S, Orange, CA 92868-3201 Ph: (714) 456-8068 |
News Archive
QLT Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for QLT091001, its oral synthetic retinoid, for the treatment of Leber Congenital Amaurosis (LCA). LCA is an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
With the rapid and continuous advances in biotechnology, scientists are better able to see inside the nucleus of a cell to unlock the secrets of its genetic material. However, what happens outside of the nucleus has, in many ways, remained a mystery. Now, researchers with the National Institutes of Health are closer to understanding how activity outside of the nucleus determines a cell's behavior.
Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.
In this week's issue of Science, researchers from the National Institute of Environmental Health Sciences (NIEHS) and Umea University in Sweden report an important discovery about a critical new role that an enzyme called DNA polymerase epsilon plays in replicating DNA in higher organisms such as yeast and perhaps even humans.
› Verified 5 days ago
Nisreen Alkhayer, Audiologist Medicare: Medicare Enrolled Practice Location: 1301 W Providence Ave, Orange, CA 92868 Phone: 714-639-4990 | |
Anna Balash, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1301 W Providence Ave, Orange, CA 92868 Phone: 714-639-4990 | |
Maria Vargas, Audiologist Medicare: Medicare Enrolled Practice Location: 904 W Town And Country Rd, Orange, CA 92868 Phone: 714-558-2666 | |
Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1940 W Orangewood Ave Ste 110, Orange, CA 92868 Phone: 714-978-2996 Fax: 714-978-2824 | |
Dr. Megan Nicole Tice, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1301 W Providence Ave, Orange, CA 92868 Phone: 714-639-4990 | |
Dr. Samantha Joy Nieves, AU.D., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 1301 W Providence Ave, Orange, CA 92868 Phone: 855-901-7742 Fax: 714-221-0977 | |
Dr. Alejandra Ocampo, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1301 W Providence Ave, Orange, CA 92868 Phone: 714-639-4991 |